• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • View form
  • Code
  • History
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

Critical appraisal:Farrell B, Godwin J, Richards S, Warlow C 1991 2

From Cancer Guidelines Wiki
Jump to:navigation, search
Jutta's exclamation mark icon.png This appraisal is pending.


Article
Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991 Dec;54(12):1044-54 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1783914.
Assigned to
User:Priyashiel.parikh
Topic area
Guidelines:Colorectal cancer/Primary Prevention
Clinical question
  • PPR1: What is the risk-benefit ratio for use of aspirin for prevention of colorectal cancer stratified by risk of colorectal cancer itself? (What is the optimal dose and frequency of administration?)
Form
Form:Quality appraisal rct-cochrane
Outcomes
Adverse events

Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Critical_appraisal:Farrell_B,_Godwin_J,_Richards_S,_Warlow_C_1991_2&oldid=120610"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.